TrialThe oncologist2022

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.

Jason M Redman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.